Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-12
1991-09-03
Kilby Scalzo, Catherine S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, 549 23, A61K 3138, C07D32702
Patent
active
050455613
ABSTRACT:
Furan sulfonamides with a saturated heterocycle fused thereto are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure.
REFERENCES:
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4820848 (1989-04-01), Ponticello et al.
patent: 4824968 (1989-04-01), Ponticello et al.
patent: 4863922 (1989-09-01), Baldwin et al.
Baldwin John J.
Ponticello Gerald S.
Selnick Harold G.
DiPrima Joseph F.
Kilby Scalzo Catherine S.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Substituted furan sulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted furan sulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted furan sulfonamides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1009696